Request Demo
Last update 07 Mar 2025
Nanjing Indetek Pharmaceutical Technology Co., Ltd.
Holding Company|
2020|
Jiangsu Sheng, China
Last update 07 Mar 2025
Overview
Tags
Skin and Musculoskeletal Diseases
Other Diseases
Infectious Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20230116
评价莫匹罗星 2%凝胶（Impetine®）治疗脓疱疮有效性和安全性的多中心、随机、开放给药、盲态评价、阳性药（百多邦®）对照的Ⅲ期临床注册研究
[Translation] A multicenter, randomized, open-label, blinded, active drug (Bactroban®)-controlled Phase III clinical registration study to evaluate the efficacy and safety of mupirocin 2% gel (Impetine®) in the treatment of impetigo
CTR20244372
评价中国健康成年受试者皮肤涂抹IDT-003凝胶的安全性、耐受性、药代动力学特征的随机、安慰剂双盲及阳性药开放对照、多剂量递增的I期临床研究
[Translation] A randomized, placebo-controlled, double-blind, and open-label, multiple-dose-escalating Phase I clinical study to evaluate the safety, tolerability, and pharmacokinetic characteristics of IDT-003 gel applied to the skin in healthy adult Chinese subjects
100 Clinical Results associated with Nanjing Indetek Pharmaceutical Technology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Nanjing Indetek Pharmaceutical Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Nanjing Indetek Pharmaceutical Technology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 10 Mar 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
1
Phase 1
Phase 3
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free